Literature DB >> 9314134

Polyenylphosphatidylcholine prevents carbon tetrachloride-induced lipid peroxidation while it attenuates liver fibrosis.

S I Aleynik1, M A Leo, X Ma, M K Aleynik, C S Lieber.   

Abstract

BACKGROUND/AIMS: Polyenylphosphatidylcholine protects against alcoholic cirrhosis in the baboon and carbon tetrachloride-induced cirrhosis in rats. This study addresses the possible mechanism of the protective effect of polyenylphosphatidylcholine.
METHODS: For 8 weeks, rats were injected with either carbon tetrachloride in peanut oil or peanut oil alone (control), and pair-fed nutritionally adequate liquid diets with equivalent amounts of linoleic acid either as polyenylphosphatidylcholine or as safflower oil. Other rats were injected for 9 weeks with heterologous albumin and fed the same liquid diets. Lipid peroxidation was measured by F2-isoprostanes and 4-hydroxynonenal.
RESULTS: Carbon tetrachloride-induced lipid peroxidation was strikingly attenuated with polyenylphosphatidylcholine supplementation. Levels of hepatic F2-isoprostanes and 4-hydroxynonenal paralleled liver fibrotic scores and collagen accumulation. Polyenylphosphatidylcholine also attenuated the fibrosis induced in rats with human albumin, but in this case, levels of hepatic 4-hydroxynonenal did not change, nor were they significantly affected by polyenylphos-phatidylcholine. Neither carbon tetrachloride injection nor polyenylphosphatidylcholine treatment changed the arachidonic acid content (a major precursor of F2-isoprostanes and 4-hydroxynonenal) in liver phospholipids, and hepatic vitamin E was not significantly altered.
CONCLUSIONS: The hepatic protection of polyenylphosphatidylcholine against carbon tetrachloride appears to be due, at least in part, to an antioxidant effect, whereas the protection against heterologous albumin-induced fibrosis suggests that an additional mechanism, such as stimulation of collagenase activity, may also be responsible.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9314134     DOI: 10.1016/s0168-8278(97)80361-3

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  24 in total

Review 1.  Current and future anti-fibrotic therapies for chronic liver disease.

Authors:  Don C Rockey
Journal:  Clin Liver Dis       Date:  2008-11       Impact factor: 6.126

2.  Comparative study on the protective effects of Yinchenhao Decoction against liver injury induced by alpha-naphthylisothiocyanate and carbon tetrachloride.

Authors:  Hong-xin Cao; Hui Sun; Xin-gang Jiang; Hai-tao Lu; Guang-mei Zhang; Xi-jun Wang; Wen-jun Sun; Ze-ming Wu; Ping Wang; Lian Liu; Jue Zhou
Journal:  Chin J Integr Med       Date:  2009-07-02       Impact factor: 1.978

Review 3.  Pathophysiological basis for antioxidant therapy in chronic liver disease.

Authors:  Jesús Medina; Ricardo Moreno-Otero
Journal:  Drugs       Date:  2005       Impact factor: 9.546

4.  Non-alcoholic fatty liver induces insulin resistance and metabolic disorders with development of brain damage and dysfunction.

Authors:  Doaa A Ghareeb; Hani S Hafez; Hend M Hussien; Nihal F Kabapy
Journal:  Metab Brain Dis       Date:  2011-09-01       Impact factor: 3.584

5.  Effects of extract from Ginkgo biloba on carbon tetrachloride-induced liver injury in rats.

Authors:  Shui-Xiang He; Jin-Yan Luo; Yue-Peng Wang; Yan-Li Wang; Han Fu; Jun-Li Xu; Gang Zhao; En-Qi Liu
Journal:  World J Gastroenterol       Date:  2006-06-28       Impact factor: 5.742

6.  Reactive oxygen species and NADPH oxidase 4 induced by transforming growth factor β1 are the therapeutic targets of polyenylphosphatidylcholine in the suppression of human hepatic stellate cell activation.

Authors:  Remina Ikeda; Kyoko Ishii; Yoshiko Hoshikawa; Junya Azumi; Yuta Arakaki; Toshihiro Yasui; Shizuka Matsuura; Yoshiaki Matsumi; Yohei Kono; Yusuke Mizuta; Akihiro Kurimasa; Ichiro Hisatome; Scott L Friedman; Hironaka Kawasaki; Goshi Shiota
Journal:  Inflamm Res       Date:  2011-02-13       Impact factor: 4.575

Review 7.  Bioconjugation of oligonucleotides for treating liver fibrosis.

Authors:  Zhaoyang Ye; Houssam S Hajj Houssein; Ram I Mahato
Journal:  Oligonucleotides       Date:  2007

8.  Ethyl pyruvate protects against experimental acute-on-chronic liver failure in rats.

Authors:  Lu-Wen Wang; Li-Kun Wang; Hui Chen; Cheng Fan; Xun Li; Can-Ming He; Zuo-Jiong Gong
Journal:  World J Gastroenterol       Date:  2012-10-28       Impact factor: 5.742

9.  Protective effect of morin on dimethylnitrosamine-induced hepatic fibrosis in rats.

Authors:  Hee-Seung Lee; Kyung Hee Jung; In-Suh Park; Sung Won Kwon; Don-Haeng Lee; Soon-Sun Hong
Journal:  Dig Dis Sci       Date:  2008-07-17       Impact factor: 3.199

10.  Protective effects of medical ozone combined with traditional Chinese medicine against chemically-induced hepatic injury in dogs.

Authors:  Li-Jie Li; Yun-Gao Yang; Zhi-Ling Zhang; Sui-Feng Nie; Ze Li; Feng Li; He-Yu Hua; Yan-Jun Hu; Hong-Shuan Zhang; Ya-Bing Guo
Journal:  World J Gastroenterol       Date:  2007-12-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.